A medtech intelligence assistant powered by Claude, tuned for North American commercialization. Ask it anything about regulatory pathways, market entry, reimbursement, or KOL strategy — right now, no signup.
Ask Apex provides general guidance. For decisions that matter, talk to Mark.
Software-driven devices don't follow the traditional device playbook. We help innovators and investors navigate what's different.
Commercial strategy for Software as a Medical Device and AI/ML-driven products — positioning, adoption planning, and market access, with regulatory specialists from Apex's network covering the evolving FDA and Health Canada frameworks.
Commercialization for products that sell into hospital IT as much as clinical departments — EHR integration strategy, security review navigation, and workflow-adoption planning.
Real-world evidence planning, health data strategy, and the economic story that convinces payers to cover intelligent devices and digital therapeutics.
Practical AI adoption inside medtech commercial organizations — market intelligence automation, sales enablement, and competitive monitoring, implemented responsibly.
Independent assessment of digital health and AI assets for PE/VC investors — is the technology real, is the regulatory path viable, will the market adopt it?
Briefings and working sessions that bring device leadership teams up to speed on what AI genuinely changes in medtech — and what remains hype.
AI-enabled devices are moving from novelty to standard of care — in imaging, diagnostics, monitoring, and surgical robotics. The companies that win will be the ones whose commercial strategy is built for that reality from day one.
Apex Medical brings both halves: two decades of device commercialization, and current, hands-on fluency in the AI and digital health landscape. That combination is rare — and it's exactly what software-driven medtech needs.